These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 2534946
1. Adoptive transfer of early and late delayed-type hypersensitivity reactions mediated by human T cells. Trial J. Reg Immunol; 1989; 2(1):14-21. PubMed ID: 2534946 [Abstract] [Full Text] [Related]
2. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. Van Loveren H, Askenase PW. J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849 [Abstract] [Full Text] [Related]
3. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors. Van Loveren H, Den Otter W, Meade R, Terheggen PM, Askenase PW. J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209 [Abstract] [Full Text] [Related]
4. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. Askenase PW, Van Loveren H, Kraeuter-Kops S, Ron Y, Meade R, Theoharides TC, Nordlund JJ, Scovern H, Gerhson MD, Ptak W. J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986 [Abstract] [Full Text] [Related]
5. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. Ptak W, Herzog WR, Askenase PW. J Immunol; 1991 Jan 15; 146(2):469-75. PubMed ID: 1987274 [Abstract] [Full Text] [Related]
8. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. Van Loveren H, Kato K, Meade R, Green DR, Horowitz M, Ptak W, Askenase PW. J Immunol; 1984 Nov 15; 133(5):2402-11. PubMed ID: 6332850 [Abstract] [Full Text] [Related]
9. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. Cher DJ, Mosmann TR. J Immunol; 1987 Jun 01; 138(11):3688-94. PubMed ID: 2953788 [Abstract] [Full Text] [Related]
11. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen. Sewell WA, Munoz JJ, Scollay R, Vadas MA. J Immunol; 1984 Oct 01; 133(4):1716-22. PubMed ID: 6206132 [Abstract] [Full Text] [Related]
13. Local passive transfer of delayed-type hypersensitivity in the mouse. Scovern H, Kantor FS. J Immunol; 1982 Jul 01; 129(1):25-9. PubMed ID: 6177751 [Abstract] [Full Text] [Related]
14. Analysis of the adoptive transfer of delayed hypersensitivity and T cell repertoire in severe combined immunodeficiency mice reconstituted with human lymphocytes. Mancia L, Mariani F, Mattei M, Montesano C, Placido R, Colizzi V, Salerno A, Bellavia A. Folia Biol (Praha); 1994 Jul 01; 40(6):411-30. PubMed ID: 7589700 [Abstract] [Full Text] [Related]
16. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. van Loveren H, Meade R, Askenase PW. J Exp Med; 1983 May 01; 157(5):1604-17. PubMed ID: 6602201 [Abstract] [Full Text] [Related]
17. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Van Loveren H, Kraeuter-Kops S, Askenase PW. Eur J Immunol; 1984 Jan 01; 14(1):40-7. PubMed ID: 6198182 [Abstract] [Full Text] [Related]
18. Cooperation between early acting delayed-type hypersensitivity T-cells and cultured effector cells in tumor rejection. Trial J. Cancer Res; 1988 Nov 01; 48(21):5922-6. PubMed ID: 3262417 [Abstract] [Full Text] [Related]